WuXi Biologics (Cayman) Inc. (WXXWY)

Market Cap	21.19B +115.2%
Revenue (ttm)	2.80B +17.2%
Net Income	585.76M +59.4%
EPS	0.14 +64.8%
Shares Out	n/a
PE Ratio	36.18
Forward PE	27.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,713
Average Volume	56,262
Open	10.05
Previous Close	9.82
Day's Range	10.05 - 10.26
52-Week Range	4.14 - 11.21
Beta	0.37
RSI	64.76
Earnings Date	Mar 20, 2026

About WuXi Biologics

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufact...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 12,552
• Stock Exchange: OTCMKTS
• Ticker Symbol: WXXWY

Financial Performance

In 2024, WuXi Biologics's revenue was 18.68 billion, an increase of 9.63% compared to the previous year's 17.03 billion. Earnings were 3.36 billion, a decrease of -1.28%.

Financial numbers in CNY